Prognostic Impact of Blood Urea Nitrogen Changes During Hospitalization in Patients With Acute Heart Failure Syndrome

  • Miura Masanobu
    Departments of Cardiovascular Medicine and Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine
  • Sakata Yasuhiko
    Departments of Cardiovascular Medicine and Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine
  • Nochioka Kotaro
    Departments of Cardiovascular Medicine and Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine
  • Takahashi Jun
    Departments of Cardiovascular Medicine and Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine
  • Takada Tsuyoshi
    Departments of Cardiovascular Medicine and Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine
  • Miyata Satoshi
    Departments of Cardiovascular Medicine and Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine
  • Hiramoto Tetsuya
    Division of Cardiology, Osaki Citizen Hospital
  • Inoue Kan-ichi
    Division of Cardiology, South Miyagi Medical Center
  • Tamaki Kenji
    Division of Cardiology, Iwate Prefectural Central Hospital
  • Shiba Nobuyuki
    Department of Cardiovascular Medicine, International University of Health and Welfare
  • Shimokawa Hiroaki
    Departments of Cardiovascular Medicine and Evidence-based Cardiovascular Medicine, Tohoku University Graduate School of Medicine

この論文をさがす

抄録

Background: Elevated blood urea nitrogen (BUN) observed in patients hospitalized for acute heart failure syndrome (AHFS) may represent increased neurohumoral activation. The purpose of this study was to examine the prognostic impact of BUN changes during hospitalization on the long-term prognosis of AHFS patients. Methods and Results: The Tohoku Acute Heart Failure Registry (n=497) is a multicenter retrospective cohort study enrolling AHFS patients who were admitted in 2007. The 337 survivors (mean age, 76 years; 52% male) were divided into 3 groups according to tertiles of BUN change during hospitalization: Decreased (D-BUN, ΔBUN (BUN level at discharge–BUN level at hospitalization) ≤–1.63mg/dl, n=112); Unchanged (U-BUN, ΔBUN –1.64 to 5.73mg/dl, n=113); Increased (I-BUN, ΔBUN >5.73mg/dl, n=112). The D-BUN group had higher prevalence of lowest glomerular filtration rate during hospitalization, whereas the I-BUN group had higher systolic blood pressure. During a median follow-up period of 2.3 years after discharge, the Kaplan-Meier curve showed that D-BUN and I-BUN had worse prognosis compared with U-BUN. Multivariable logistic model showed that all-cause death was more frequent in I-BUN (hazard ratio, 2.94; 95% confidence interval, 1.51–5.73; P<0.001). Subgroup analysis revealed that BUN increase during hospitalization was associated with all-cause death, regardless of renal function. Conclusions: AHFS patients with a BUN increase during hospitalization have worse long-term prognosis, independent of renal function.  (Circ J 2013; 77: 1221–1228)<br>

収録刊行物

  • Circulation Journal

    Circulation Journal 77 (5), 1221-1228, 2013

    一般社団法人 日本循環器学会

被引用文献 (5)*注記

もっと見る

参考文献 (24)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ